Retatrutide (GP3), often referred to as “triple G,” is an advanced multi-receptor peptide currently being explored in research settings for its activity across GLP-1, GIP, and glucagon pathways. This triple agonist profile makes it a unique compound of interest for studies focused on metabolic regulation, energy balance, and weight-related mechanisms.
By engaging multiple hormone receptors simultaneously, Retatrutide (GP3) is being researched for its potential to influence appetite signaling, glucose metabolism, and energy expenditure in controlled environments. Its multi-pathway approach sets it apart from single or dual agonist compounds.
Product Details:
Compound: Retatrutide (GP3)
Format: Designed for use with a preloaded, easy-to-use delivery system
Application: Research use only
Key Features:
Easy to use, hassle-free, preloaded and ready to use
